-
1
-
-
4644328982
-
XP13512 [(±)-1-([(α-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: I. Design, synthesis, enzymatic conversion to gabapentin, and transport by intestinal solute transporters
-
Cundy, K.C., Branch, R., Chernov-Rogan, T. et al. XP13512 [(±)-1-([(α-isobutanoyloxyethoxy)carbonyl]aminomethyl) -1-cyclohexane acetic acid], a novel gabapentin prodrug: I. Design, synthesis, enzymatic conversion to gabapentin, and transport by intestinal solute transporters. J Pharmacol Exp Ther 2004, 311(1): 315-23.
-
J Pharmacol Exp Ther 2004
, vol.311
, Issue.1
, pp. 315-323
-
-
Cundy, K.C.1
Branch, R.2
Chernov-Rogan, T.3
-
2
-
-
33845331204
-
Crystalline form of gamma-aminobutyric acid analog
-
(XenoPort, Inc.). WO 2005037784
-
Estrada, T., Raillard, S.P., Frauenfelder, C., Zacher, U. (XenoPort, Inc.). Crystalline form of gamma-aminobutyric acid analog. WO 2005037784.
-
-
-
Estrada, T.1
Raillard, S.P.2
Frauenfelder, C.3
Zacher, U.4
-
3
-
-
33845308029
-
Prodrugs of GABA analogs, compositions and uses thereof
-
(XenoPort, Inc.). EP 1404324, JP 2004536873, US 2003176398, WO 02100347
-
Gallop, M.A., Cundy, K.C., Zhou, C.X., Yao, F., Xiang, J.-N., Oilman, I.R., Qiu, F.G. (XenoPort, Inc.). Prodrugs of GABA analogs, compositions and uses thereof. EP 1404324, JP 2004536873, US 2003176398, WO 02100347.
-
-
-
Gallop, M.A.1
Cundy, K.C.2
Zhou, C.X.3
Yao, F.4
Xiang, J.-N.5
Oilman, I.R.6
Qiu, F.G.7
-
4
-
-
33845308029
-
Prodrugs of GABA analogs, compositions and uses thereof
-
(XenoPort, Inc.). JP 2006509031, US 2004077553, WO 2004052844
-
Gallop, M.A., Cundy, K.C., Zhou, C.X., Qiu, F.G., Yao, F., Xiang, J.-N., Oilman, I.R. (XenoPort, Inc.). Prodrugs of GABA analogs, compositions and uses thereof. JP 2006509031, US 2004077553, WO 2004052844.
-
-
-
Gallop, M.A.1
Cundy, K.C.2
Zhou, C.X.3
Qiu, F.G.4
Yao, F.5
Xiang, J.-N.6
Oilman, I.R.7
-
5
-
-
84938386045
-
Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
-
(XenoPort, Inc.) WO 2005066122
-
Gallop, M.A., Dai, X., Scheuerman, R.A. et al. (XenoPort, Inc.). Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof. WO 2005066122.
-
-
-
Gallop, M.A.1
Dai, X.2
Scheuerman, R.A.3
-
6
-
-
33845348014
-
Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
-
(XenoPort, Inc.) US 2004014940
-
Raillard, S.P., Zhou, C.X., Yao, F., Manthati, S.K., Xiang, J.-N., Gallop, M.A. (XenoPort, Inc.). Methods for synthesis of acyloxyalkyl derivatives of GABA analogs. US 2004014940.
-
-
-
Raillard, S.P.1
Zhou, C.X.2
Yao, F.3
Manthati, S.K.4
Xiang, J.-N.5
Gallop, M.A.6
-
7
-
-
21744445935
-
Restless legs syndrome prevalence and impact: REST general population study
-
Allen, R.P., Walters, A.S., Montplaisir, J., Hening, W., Myers, A., Bell, T.J., Ferini-Strambi, L. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005, 165(11): 1286-92.
-
(2005)
Arch Intern Med
, vol.165
, Issue.11
, pp. 1286-1292
-
-
Allen, R.P.1
Walters, A.S.2
Montplaisir, J.3
Hening, W.4
Myers, A.5
Bell, T.J.6
Ferini-Strambi, L.7
-
8
-
-
21044452482
-
New paradigms in the treatment of restless legs syndrome
-
Thorpy, M.J. New paradigms in the treatment of restless legs syndrome. Neurology 2005, 64(12, Suppl. 3): S28-33.
-
(2005)
Neurology
, vol.64
, Issue.12 SUPPL. 3
-
-
Thorpy, M.J.1
-
10
-
-
0034656124
-
Management of herpes zoster (shingles) and postherpetic neuralgia
-
Stankus, S.J., Dlugopolski, M., Packer, D. Management of herpes zoster (shingles) and postherpetic neuralgia. Am Fam Physician 2000, 61(8): 2437-48.
-
(2000)
Am Fam Physician
, vol.61
, Issue.8
, pp. 2437-2448
-
-
Stankus, S.J.1
Dlugopolski, M.2
Packer, D.3
-
11
-
-
0032819783
-
Gabapentin in the management of convulsive disorders
-
McLean, M.J. Gabapentin in the management of convulsive disorders. Epilepsia 1999, 40(Suppl. 6): S39-50.
-
(1999)
Epilepsia
, vol.40
, Issue.SUPPL. 6
-
-
McLean, M.J.1
-
12
-
-
0034750718
-
Postherpetic Neuralgia Study Group: Gabapentin in postherpetic neuralgia: A randomized, double blind, placebo controlled study
-
Rice, A.S., Maton, S. Postherpetic Neuralgia Study Group: Gabapentin in postherpetic neuralgia: A randomized, double blind, placebo controlled study. Pain 2001, 94(2): 215-24.
-
(2001)
Pain
, vol.94
, Issue.2
, pp. 215-224
-
-
Rice, A.S.1
Maton, S.2
-
13
-
-
0027402753
-
A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma
-
Stewart, B.H., Kugler, A.R., Thompson, P.R., Bockbrader, H.N. A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma. Pharm Res 1993, 10(2): 276-81.
-
(1993)
Pharm Res
, vol.10
, Issue.2
, pp. 276-281
-
-
Stewart, B.H.1
Kugler, A.R.2
Thompson, P.R.3
Bockbrader, H.N.4
-
14
-
-
0037180403
-
Treatment of restless legs syndrome with gabapentin: A double-blind, cross-over study
-
Garcia-Borreguero, D., Larrosa, O., de la Llave, Y., Verger, K., Masramon, X., Hernandez, G. Treatment of restless legs syndrome with gabapentin: A double-blind, cross-over study. Neurology 2002, 59: 1573-9.
-
(2002)
Neurology
, vol.59
, pp. 1573-1579
-
-
Garcia-Borreguero, D.1
Larrosa, O.2
De La Llave, Y.3
Verger, K.4
Masramon, X.5
Hernandez, G.6
-
15
-
-
0032477294
-
Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial
-
Backonja, M., Beydoun, A., Edwards, K.R. et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. JAMA - J Am Med Assoc 1998, 280(21): 1831-6.
-
(1998)
JAMA - J Am Med Assoc
, vol.280
, Issue.21
, pp. 1831-1836
-
-
Backonja, M.1
Beydoun, A.2
Edwards, K.R.3
-
16
-
-
4644251930
-
XP13512 [(±)-1-([(α-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: II. Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkeys
-
Cundy, K.C., Annamalai, T., Bu, L. et al. XP13512 [(±)-1- ([(α-isobutanoyloxyethoxy)carbonyl]aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: II. Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkeys. J Pharmacol Exp Ther 2004, 311(1): 324-33.
-
(2004)
J Pharmacol Exp Ther
, vol.311
, Issue.1
, pp. 324-333
-
-
Cundy, K.C.1
Annamalai, T.2
Bu, L.3
-
17
-
-
33845314146
-
XP 13512, a transported prodrug of gabapentin, overcomes the saturable oral absorption of Neurontin® in humans
-
(March 26-30, Atlanta) Abst MEDI-222
-
Raillard, S.P. XP 13512, a transported prodrug of gabapentin, overcomes the saturable oral absorption of Neurontin® in humans. 231st ACS Natl Meet (March 26-30, Atlanta) 2006, Abst MEDI-222.
-
(2006)
231st ACS Natl Meet
-
-
Raillard, S.P.1
-
18
-
-
33845295933
-
New strategies in medicinal chemistry: Harnessing nutrient transport mechanisms to drug absorption and disposition in vivo
-
(Aug 22-26, Philadelphia) Abst MEDI-19
-
Gallop, M.A. New strategies in medicinal chemistry: Harnessing nutrient transport mechanisms to drug absorption and disposition in vivo. 228th ACS Natl Meet (Aug 22-26, Philadelphia) 2004, Abst MEDI-19.
-
(2004)
228th ACS Natl Meet
-
-
Gallop, M.A.1
-
19
-
-
33845337793
-
Single- and multi-dose phase 1 studies of XP13512, a transported prodrug of gabapentin, demonstrate safety, tolerability, and dose-proportional gabapentin pharmacokinetics
-
(Nov 4-6, Bermuda)
-
Canafax, D.M., Moors, T.L., Cundy, K.C. Single- and multi-dose phase 1 studies of XP13512, a transported prodrug of gabapentin, demonstrate safety, tolerability, and dose-proportional gabapentin pharmacokinetics. 7th Intl Conf Mech Treatment Neuropathic Pain (Nov 4-6, Bermuda) 2004.
-
(2004)
7th Intl Conf Mech Treatment Neuropathic Pain
-
-
Canafax, D.M.1
Moors, T.L.2
Cundy, K.C.3
-
20
-
-
33845329013
-
A phase 1 randomized, cross over, single dose study of the safety. tolerability, and pharmacokinetics of XP13512 sustained release tablets vs. Neurontin[R] in healthy adult subjects
-
(Nov 4-6, Bermuda)
-
Fenney, L.J., Canafax, D.M., Moors, T.L., Cundy, K.C. A phase 1 randomized, cross over, single dose study of the safety. tolerability, and pharmacokinetics of XP13512 sustained release tablets vs. Neurontin[R] in healthy adult subjects. 7th Intl Conf Mech Treatment Neuropathic Pain (Nov 4-6, Bermuda) 2004.
-
(2004)
7th Intl Conf Mech Treatment Neuropathic Pain
-
-
Fenney, L.J.1
Canafax, D.M.2
Moors, T.L.3
Cundy, K.C.4
-
21
-
-
33845305966
-
XP13512 improves symptoms and sleep disturbance in RLS patients: Results of a 2-week, randomized, double-blind, placebo-controlled cross-over polysomnography trial
-
[20th Annu Meet Assoc Sleep Soc (June 17-22, Salt Lake City) 2006] (Abst): Abst 0818
-
Kushida, C.A., Becker, P.M., Perkins, T., Thein, S., Walters, A., Canafax, D.M. XP13512 improves symptoms and sleep disturbance in RLS patients: Results of a 2-week, randomized, double-blind, placebo-controlled cross-over polysomnography trial. Sleep [20th Annu Meet Assoc Sleep Soc (June 17-22, Salt Lake City) 2006] 2006, 29(Abst): Abst 0818.
-
(2006)
Sleep
, vol.29
-
-
Kushida, C.A.1
Becker, P.M.2
Perkins, T.3
Thein, S.4
Walters, A.5
Canafax, D.M.6
-
22
-
-
33747143889
-
XP13512 is well-tolerated and effective in treating moderate to severe RLS in a 2-week, randomized, double-blind, placebo-controlled exploratory trial
-
[58th Annu Meet Am Acad Neurol (AAN) (April 1-8, San Diego) 2006] Abst EV2.006
-
Kushida, C.A., Becker, P.M., Ellenbogen, A.L., Walters, A., Canafax, D.M. XP13512 is well-tolerated and effective in treating moderate to severe RLS in a 2-week, randomized, double-blind, placebo-controlled exploratory trial. Neurology [58th Annu Meet Am Acad Neurol (AAN) (April 1-8, San Diego) 2006] 2006, 66(5, Suppl. 2): Abst EV2.006.
-
(2006)
Neurology
, vol.66
, Issue.5 SUPPL. 2
-
-
Kushida, C.A.1
Becker, P.M.2
Ellenbogen, A.L.3
Walters, A.4
Canafax, D.M.5
-
23
-
-
33845348317
-
Gabapentin exposure and pain reduction in patients with postherpetic neuralgia: Analysis of a phase 2a randomized, double-blind, placebo-controlled study of Neurontin® and XP13512
-
(May 3-6, San Antonio) Abst 745
-
Backonja, M., Cundy, K.C., Canafax, D.M. Gabapentin exposure and pain reduction in patients with postherpetic neuralgia: Analysis of a phase 2a randomized, double-blind, placebo-controlled study of Neurontin® and XP13512. Am Pain Soc Annu Meet (May 3-6, San Antonio) 2006, Abst 745.
-
(2006)
Am Pain Soc Annu Meet
-
-
Backonja, M.1
Cundy, K.C.2
Canafax, D.M.3
-
24
-
-
33845296264
-
XenoPort initiates phase 3 clinical program for XP13512 as a treatment for restless legs syndrome
-
March 14
-
XenoPort initiates phase 3 clinical program for XP13512 as a treatment for restless legs syndrome. XenoPort Press Release March 14, 2006.
-
(2006)
XenoPort Press Release
-
-
|